‘PATH to PD’ Program Seeks to Deepen Understanding of Parkinson’s Onset, Progression
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) will fund a new program to investigate the pathogenesis of…
Articles by Ana de Barros, PhD
Michael J. Fox Foundation Announces New $7M Initiative to Support Parkinson’s Research, Therapy Development
The Michael J. Fox Foundation (MJFF) announced a new $7 million funding program to support Parkinson’s disease research and…
Parkinson’s Advocates Will Explain Research and Care Needs to Congress
More than 300 Parkinson’s disease experts and advocates from across the United States will discuss critical needs in research and public…
Neurocrine to Ask FDA to Begin Reviewing Parkinson’s Therapy Ongentys in 2019
Neurocrine Biosciences will ask the U.S. Food and Drug Administration in early 2019 to begin the  regulatory review process that…
Parkinson Voice Project Offering Grants to Help Groups Use Its Speech Therapy Program
Parkinson Voice Project, a nonprofit focused on speech therapy, is accepting applications for its National Grant Program that aims…
Parkinson’s Foundation Receives $450,000 Gift from Terranova to Expand Centers of Excellence Network
Stephen Bittel, founder and chairman of Terranova, has donated $450,000 to the Miami-based Parkinson’s Foundation to fund the expansion…
Wearable Sensors Tracking Exercise Show Potential in Parkinson’s But Better Studies Needed, Team Says
Researchers at Cedars-Sinai found existing evidence does not support claims that wearable biosensors are improving outcomes for patients with various…
Parkinson’s Disease Digital Biomarker DREAM Challenge Winners Announced
The winners of a crowd-sourced research challenge designed to improve the ability of remote sensors to monitor Parkinson’s…
Parkinson’s Foundation Enrolls 10,000th Patient in Largest Clinical Trial of the Disease Ever
The Parkinson’s Foundation has enrolled the 10,000th patient in the largest clinical trial of the disease yet to be conducted.
Adamas Is Getting the Word Out on Its Parkinson’s Muscle Control Therapy
Adamas Pharmaceuticals is making a concerted effort to spread the word on its flagship treatment for the involuntary muscle movements that…